Brain Injuries, Traumatic Clinical Trial
Official title:
Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury
NCT number | NCT05057377 |
Other study ID # | 20-0300 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 22, 2021 |
Est. completion date | August 31, 2022 |
Verified date | March 2023 |
Source | The University of Texas Medical Branch, Galveston |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Traumatic brain injury (TBI) due to trauma and/or neurologic disease is a leading cause of long-term disability in the United States. The loss of balance for people with a traumatic brain injury can have a large effect on their walking abilities and this can come with a number of challenges. There is a greater risk of falling after being discharged from the hospital. In addition, people are more likely to become sedentary after TBI, which leads to the loss of muscle strength. To help provide the best care, clinicians need accurate measurements when people begin their therapy, as well as throughout to ensure they are making appropriate progress. The tests currently used by clinicians may not provide the most accurate measurements that show what a person is capable of physically doing. The study you are being asked to participate in aims to provide more accurate measurements by using a robotic treadmill device and by assessing motivating factors that are important to you. The treadmill device will allow us to more accurately test your walking ability in a safe, fall-free environment.
Status | Completed |
Enrollment | 16 |
Est. completion date | August 31, 2022 |
Est. primary completion date | August 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults ages 18 years and older - All demographic groups will be invited to participate and would have equal access - Post-TBI individuals currently enrolled at the Moody Neurorehabilitation Institute - Ambulatory with or without assistive devices - Subjects with expressive aphasia in the case of a caregiver able to provide assistance when needed - English-speaking only - Medically stable (controlled hypertension, no arrhythmia, stable cardiovascular status) - Able to provide written informed consent Exclusion Criteria: - Subjects with loss of lower limb - History of serious cardiac disease (e.g., myocardial infarction) - Uncontrolled blood pressure (systolic pressure >140 mmHg, diastolic blood pressure >90 mmHg) - Subjects with receptive aphasia - Presence of cerebellar and brainstem deficits - Severe cognitive disorder - Uncontrolled respiratory or metabolic disorders - Major or acute musculoskeletal problems - Spasticity management that included phenol block injections within 12 months or botulinum toxin injections within 4 months of the study - Participants undergoing any rehabilitation therapy during the timeframe of this study. - Body weight greater than 250 pounds (due to robotic device weight restrictions) - Non-English speaking individuals |
Country | Name | City | State |
---|---|---|---|
United States | Moody Neurorehabilitation Institute at Galveston | Galveston | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas Medical Branch, Galveston |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in 10-Meter Walk Test-Overground | The 10-meter walk test assess walking speed in meters per second over a short duration. | Baseline, pre-intervention. | |
Primary | Change in 5x Sitting to Standing Resistance Test | In order to measure walking strength, participants will be asked to perform a Sit-to-Stand test. Beginning from a sitting position, a participant is asked to stand and return to a seated position. They will be asked to repeat this procedure 5 times. | Baseline, pre-intervention. | |
Primary | 6-Minute Walk Test | In order to measure walking endurance, participants will be asked to walk as far as they are able to comfortably walk during a 6 minute time period, with the total distance (in meters) being the outcome. | Baseline, pre-intervention. | |
Primary | Top Walking Speed/Max Tolerated using Robotic Device | In order to measure walking speed, and with the assistance of the safety enhanced robotic-treadmill device, a participant's maximum walking speed will be measured in meters per second. | During the intervention. | |
Primary | Deadband Resistance/Max Tolerated using Robotic Device | In order to measure walking strength, participants will be asked to walk on the robotic-treadmill device as fast as they can over a series of trials. Resistance of the treadmill will be increased until a maximum is reached and recorded. | During the intervention. | |
Primary | 6-Minute Walk Test using Robotic Device | In order to measure walking endurance, participants will be asked to walk as far as they are able to comfortably walk during a 6 minute time period while using the robotic-treadmill device. | During the intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04111549 -
GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth
|
N/A | |
Recruiting |
NCT05097261 -
Ketamine in Acute Brain Injury Patients.
|
Phase 4 | |
Completed |
NCT03504709 -
REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
|
||
Recruiting |
NCT03899532 -
Remote Ischemic Conditioning in Traumatic Brain Injury
|
N/A | |
Withdrawn |
NCT02776488 -
Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)
|
Phase 2 | |
Completed |
NCT02426749 -
Treatment and Recovery Monitoring of Post TBI Symptoms
|
N/A | |
Completed |
NCT01339702 -
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
|
||
Recruiting |
NCT05977270 -
The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury
|
N/A | |
Recruiting |
NCT04666766 -
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
|
N/A | |
Active, not recruiting |
NCT04559724 -
Gait Training Through a Novel Over-ground Wearable Robotic System in People With Pyramidal Hemisyndromes
|
N/A | |
Not yet recruiting |
NCT04515420 -
The Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain Injury
|
||
Not yet recruiting |
NCT05569993 -
Glutamine and Traumatic Brain Injury
|
Early Phase 1 | |
Recruiting |
NCT04331392 -
Online Memory Intervention for Individuals With Traumatic Brain Injury
|
N/A | |
Completed |
NCT03727737 -
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI
|
N/A | |
Completed |
NCT03153397 -
Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)
|
N/A | |
Completed |
NCT02004080 -
CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in Europe
|
||
Completed |
NCT01336413 -
Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans
|
Phase 2 | |
Completed |
NCT04957563 -
Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia
|
N/A | |
Completed |
NCT05179330 -
Visual Feedback in Lower Limb Rehabilitation
|
N/A | |
Completed |
NCT05397704 -
Brain Oximeter Calibration and Validation Study
|
N/A |